PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on September 27, 2018, following the Company's Annual Meeting of Stockholders. The filing details significant changes to the Board of Directors, the approval of an amendment to the Equity Incentive Plan, and the ratification of the independent auditor.
Key Financial Metrics
The filing does not provide current period revenue, profit, cash flow, or margin data. However, it references a prior financing event:
- Convertible Notes: On August 1, 2018, the Company sold Convertible Promissory Notes with an aggregate principal amount of $23.6 million.
- Conversion Terms: The notes are convertible into common stock at a price of $2.13 per share.
- Director Investment: Newly appointed director H. Douglas Evans invested $200,000 in this note offering.
Material Changes
Board of Directors Resignations and Appointments
- Resignations: Frank C. Ingriselli (former Chairman) and Elizabeth P. Smith (Chairperson of the Compensation Committee) resigned effective September 27, 2018, to pursue other opportunities. The resignations were not related to any disagreement with the Company.
- Board Size Reduction: The Board size was decreased to four members.
- New Appointment: H. Douglas Evans was appointed as a director and determined to be "independent." He was appointed to the Compensation Committee, Audit Committee, and Nominating and Corporate Governance Committee (as Chairman).
- Leadership Change: John J. Scelfo was appointed as the new Chairman of the Board of Directors.
Equity Incentive Plan Amendment
- Stockholders approved an amendment to the 2012 Equity Incentive Plan to increase the number of shares reserved for issuance by 3,000,000, bringing the total to 6,000,000 shares.
Director Compensation Awards
On September 27, 2018, the following awards were granted to non-employee directors:
- John J. Scelfo: 20,000 restricted shares (vesting July 12, 2019) and options to purchase 120,000 shares (exercise price $2.19, vesting July 12, 2019).
- H. Douglas Evans: 20,000 restricted shares (vesting September 27, 2019) and options to purchase 100,000 shares (exercise price $2.19, vesting September 27, 2019).
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard disclosure that the resignations were not due to disagreements. The Company issued a press release on October 1, 2018, regarding these matters.
Investor Verification Checklist
- Verify the impact of the $23.6 million convertible note issuance on the Company's capital structure and potential dilution at the $2.13 conversion price.
- Confirm the new Board composition and the independence status of the new director, H. Douglas Evans.
- Review the full text of the amended 2012 Equity Incentive Plan (Exhibit 4.1) to understand the terms of the increased share reserve.
- Monitor the vesting schedules for the new director equity awards to assess future dilution.
- Check subsequent filings for the Company's operational performance, as this 8-K does not contain financial results.